Sign Up | Log In | What is SocialPicks?

Auxilium Pharmaceuticals Inc. (AUXL) Trade Now » Rate AUXL - Discuss AUXL - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

92.5%

Top:

100.0%

Rate AUXL:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

AUXL: Bull or Bear?

From: SocialPicks | Blogsphere | All

From the Blogosphere

Friday's Upgrades and Downgrades

2 %

<>

UPGRADES
F5 Networks FFIV Citigroup Hold » Buy
Community Health CYH Stifel Nicolaus Hold » Buy
Gerdau S.A. GGB Citigroup Hold » Buy
Parametric PMTC Kaufman Bros Hold » Buy
InterActive IACI Lehman Brothers Equal-weight » Overweight
Newmont Mining NEM RBC Capital Mkts Underperform » Sector Perform
China Life Insurance LFC Bear Stearns Underperform » Peer Perform
DPL Inc. DPL Robert W. Baird Neutral » Outperform
FARO Techs FARO Robert W. Baird Neutral » Outperform
Monaco Coach MNC Robert W. Baird Neutral » Outperform
Kendle KNDL Robert W. Bair...

Continue reading »

By Todd Sullivan (-25.49% risk: aggressive) 11/02/07

Comment

Friday's Upgrades and Downgrades

Continue reading »

By Todd Sullivan (+0.00%) 11/02/07

Comment

« previous
1
2
3
« next

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
BIDU	Baiducom Inc ADS
WFC	Wells Fargo & Company
V	Visa Inc
IBM	International Business Machines Corp
FSLR	First Solar Inc.
MO	Altria Group Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

StreetInsider.com on AUXL

Visit streetinsider.com

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Auxilium Pharmaceuticals Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.